GE HealthCare Technologies EPS - Earnings per Share 2020-2023 | GEHC
GE HealthCare Technologies annual and quarterly earnings per share history from 2020 to 2023. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- GE HealthCare Technologies EPS for the quarter ending December 31, 2023 was $0.89, a 27.05% decline year-over-year.
- GE HealthCare Technologies EPS for the twelve months ending December 31, 2023 was $3.03, a 28.2% decline year-over-year.
- GE HealthCare Technologies 2023 annual EPS was $3.03, a 28.2% decline from 2022.
- GE HealthCare Technologies 2022 annual EPS was $4.22, a 14.75% decline from 2021.
- GE HealthCare Technologies 2021 annual EPS was $4.95, a INF% increase from 2020.
| GE HealthCare Technologies Annual EPS | |
|---|---|
| 2023 | $3.03 |
| 2022 | $4.22 |
| 2021 | $4.95 |
| 2020 | $0.00 |
| 2019 | $0.00 |
| GE HealthCare Technologies Quarterly EPS | |
|---|---|
| 2023-12-31 | $0.89 |
| 2023-09-30 | $0.82 |
| 2023-06-30 | $0.91 |
| 2023-03-31 | $0.41 |
| 2022-12-31 | $1.22 |
| 2022-09-30 | $1.07 |
| 2022-06-30 | $1.07 |
| 2022-03-31 | $0.86 |
| 2021-12-31 | $0.00 |
| 2021-09-30 | $0.00 |
| 2020-12-31 | $0.00 |
| 2019-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $36.426B | $19.552B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems (INSP) | United States | $7.603B | 0.00 |
| Axonics (AXNX) | United States | $3.448B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.323B | 0.00 |
| 10x Genomics (TXG) | United States | $3.247B | 0.00 |
| Azenta (AZTA) | United States | $3.087B | 251.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.879B | 0.00 |
| Enovis (ENOV) | United States | $2.793B | 20.70 |
| Hims & Hers Health (HIMS) | United States | $2.496B | 0.00 |
| Privia Health (PRVA) | United States | $2.264B | 100.42 |
| Schrodinger (SDGR) | United States | $1.739B | 0.00 |
| Omnicell (OMCL) | United States | $1.377B | 47.59 |
| Phreesia (PHR) | United States | $1.279B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.865B | 0.00 |
| Standard BioTools (LAB) | United States | $0.719B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
| Talkspace (TALK) | United States | $0.539B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.410B | 0.00 |
| Pulmonx (LUNG) | United States | $0.360B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.357B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.329B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.229B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.202B | 0.00 |
| Outset Medical (OM) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.164B | 0.00 |
| Augmedix (AUGX) | United States | $0.132B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.07 |
| 111 (YI) | China | $0.097B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.081B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.074B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| Zepp Health (ZEPP) | China | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
| Movano (MOVE) | United States | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |